You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Unresectable prostate cancer

Showing 9926 - 9950 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia (CLL) Trial in United States (Obinutuzumab, Venetoclax)

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Basking Ridge, New Jersey
  • +6 more
Jan 3, 2023

Tumors, Coronavirus Trial in United States

Recruiting
  • Neoplasms
  • Coronavirus
    • Birmingham, Alabama
    • +84 more
    Feb 23, 2022

    Ovarian Cancer, Epithelial Trial in Nanjing (Envafolimab, Lenvatinib, VP-16)

    Not yet recruiting
    • Ovarian Cancer, Epithelial
    • Nanjing, Jiangsu, China
      Zhongda Hospital
    Jun 13, 2022

    Fruquintinib in the Cross-line Treatment of Refractory mCRC

    Recruiting
    • Fruquintinib
    • Metastatic Colorectal Cancer
    • Wuhan, Hubei, China
    • +2 more
    Oct 23, 2023

    Lung Cancer Metastatic, EGFR Gene Mutation Trial in San Francisco (Osimertinib, Alisertib)

    Recruiting
    • Lung Cancer Metastatic
    • EGFR Gene Mutation
    • San Francisco, California
      University of California, San Francisco
    Aug 10, 2022

    Breast Cancer Trial (Exercise Timing Groups)

    Not yet recruiting
    • Breast Cancer
    • Exercise Timing Groups
    • (no location specified)
    Apr 6, 2023

    Renal Cell Carcinoma Trial (Internet-Based Intervention - Complete iConquerFear program, Quality-of-Life Assessment,

    Withdrawn
    • Renal Cell Carcinoma
    • Internet-Based Intervention - Complete iConquerFear program
    • +2 more
    • (no location specified)
    Jun 7, 2022

    Chemo, Gastric Cancer Trial in Guangzhou (FLOT(Docetaxel+oxaliplatin+leucovorin+5-FU), Treprizumab, Tiggio capsule (S-1))

    Recruiting
    • Chemotherapy
    • Gastric Cancer
    • FLOT(Docetaxel+oxaliplatin+leucovorin+5-FU), Treprizumab, Tiggio capsule (S-1)
    • Guangzhou, Guangdong, China
      Guangdong Province Hospital of Chinese Medicine, the Second Affi
    May 10, 2021

    Adults and Children Who May Be At Risk for Hereditary Forms of

    Recruiting
    • Cancer
    • Family History Information
    • +3 more
    • Basking Ridge, New Jersey
    • +6 more
    Feb 11, 2022

    Cancer Trial in Rochester (Tissue Collection, Blood Collection, Buccal Swab)

    Recruiting
    • Cancer
    • Tissue Collection
    • +2 more
    • Rochester, Minnesota
      Mayo Clinic
    May 12, 2022

    Pancreatic Cancer, Metastatic Adenocarcinoma Trial in Winston-Salem (Nab paclitaxel, Gemcitabine, TheraBionic)

    Not yet recruiting
    • Pancreatic Cancer
    • Metastatic Adenocarcinoma
    • Nab paclitaxel
    • +2 more
    • Winston-Salem, North Carolina
      Wake Forest Baptist Comprehensive Cancer Center
    Mar 8, 2023

    Recurrent ALK Positive Large B-Cell Lymphoma, Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between

    Not yet recruiting
    • Recurrent ALK Positive Large B-Cell Lymphoma
    • +28 more
    • Biospecimen Collection
    • +5 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Aug 17, 2022

    Breast Cancer Stage I Trial (Capecitabine,Pyrotinib)

    Not yet recruiting
    • Breast Cancer Stage I
    • (no location specified)
    May 7, 2023

    Breast Cancer Trial in Groningen (Palbociclib, FES PET, Letrozole)

    Completed
    • Breast Cancer
    • Groningen, Netherlands
      University Medical Center Groningen
    Oct 11, 2022

    Resectable Head and Neck Squamous Cell Carcinoma Trial in Milwaukee (42 Gy Radiation Therapy, 39 Gy Radiation Therapy, 32.5 Gy

    Suspended
    • Resectable Head and Neck Squamous Cell Carcinoma
    • 42 Gy Radiation Therapy
    • +2 more
    • Milwaukee, Wisconsin
      Froedtert & the Medical College of Wisconsin
    Jan 13, 2023

    Carcinoma, Hepatocellular Trial in Worldwide (Refametinib (BAY86-9766))

    Completed
    • Carcinoma, Hepatocellular
    • Refametinib (BAY86-9766)
    • Washington, District of Columbia
    • +57 more
    Apr 6, 2021

    Urinary Bladder Tumors Trial in Worldwide (drug, other, biological)

    Active, not recruiting
    • Urinary Bladder Neoplasms
    • Aurora, Colorado
    • +102 more
    Nov 16, 2022

    Healthy Participants Trial in Salt Lake City (DC-806, Midazolam, Repaglinide)

    Not yet recruiting
    • Healthy Participants
    • Salt Lake City, Utah
      ICON Phase 1 Clinic
    Oct 16, 2023

    Metastatic Lung Cancer Trial in France (InvisionFirst® molecular panel)

    Active, not recruiting
    • Metastatic Lung Cancer
    • InvisionFirst® molecular panel
    • Bayeux, France
    • +15 more
    Aug 22, 2022

    Collection of Head Images During Radiotherapy

    Recruiting
    • Head and Neck Neoplasms
    • Radiation Therapy Complication
      • Blacktown, New South Wales, Australia
        Blacktown Hospital
      Jan 25, 2023

      Recurrent Head and Neck Squamous Cell Carcinoma, Metastatic Head-and-neck Squamous-cell Carcinoma, Locally Advanced Cutaneous

      Active, not recruiting
      • Recurrent Head and Neck Squamous Cell Carcinoma
      • +3 more
      • 200 mg Pembrolizumab
      • +2 more
      • Miami, Florida
      • +6 more
      Jan 9, 2023

      Enrolling Advanced Prostate Cancer Who Are to Receive

      Completed
      • Castrate Refractory Metastatic Prostate Cancer (mCRPC)
      • Scottsdale, Arizona
        21st Century Oncology
      Jan 8, 2019

      Stage III Solid Tumors, Stage IV Solid Tumors Trial (Comprehensive molecular panel test, EORTC QLQ-30)

      Not yet recruiting
      • Stage III Solid Tumors
      • Stage IV Solid Tumors
      • Comprehensive molecular panel test
      • EORTC QLQ-30
      • (no location specified)
      Jan 25, 2023

      Epithelial Ovarian Carcinoma Stage III, Epithelial Ovarian Carcinoma Stage IV, Fallopian Tube Carcinoma Stage III Trial in China

      Recruiting
      • Epithelial Ovarian Carcinoma Stage III
      • +5 more
      • nab-paclitaxel combined with carboplatin
      • Guangzhou, Guangdong, China
      • +10 more
      Feb 19, 2023

      Follow-up in People With Basal Cell Carcinoma

      Not yet recruiting
      • Basal Cell Carcinoma
      • Digital Dermoscopy
      • +4 more
      • New York, New York
        Memorial Sloan Kettering Cancer Center (All Protocol Activities)
      Jul 21, 2022